National and Kapodistrian University of Athens
Το μοντέλο έκφρασης των υποδοχέων σωματοστατίνης, Kiss-1 και του υποδοχέα GPR54 στον καρκίνο της ουροδόχου κύστης
Abstract
dc:descriptionBladder cancer is the 4th most common cancer in men and the 9th most common cancer in female in developed countries. The prognosis of bladder cancer become worse with advancing stage. Five year survival rate drops from 80-90% in superficial cancer to only 10-15% in metastatic cancer. Risks factors for tumor progression and recurrence include previous tumor recurrence rate, number of tumors, tumor diameter, tumor stage, tumor grade and the presence of carcinoma in situ. Unfortunately, these clinicopathological parameters are limited in their prognostic ability. Therefore identification of molecular determinant of disease progression could provide more specific prognostic information and could be translated into new approaches for drug and biomarker development. In the present study we evalutated for the first time the expression pattern of Kiss1, GPR54 and of the somatostatin receptors 1-5 (SSTRs) in bladder cancer. We initially collected 73 samples from 64 patients, 59 pathological with bladder cancer and 14 with normal urothelium. There were no expression neither of Kiss 1 nor of GPR54. With regard to the SSTRs, SSTR1 was expressed in 24 samples, SSTR2 in 15 samples, SSTR3 in 23 samples, SSTR4 in 16 samples and SSTR5 in all but one. Patients were stratified according to disease status ie normal and pathological, according to stage ie superficial and muscle invasive and according to the presentation ie first presentation or recurrence. Bladder cancer tissue samples expressed lower levels of SSTR3 (p=0.03). We also studied the co-expression patterns of SSTRs in the bladder cancer tissue samples. In 8 cases SSTR5 was the only SSTR expressed, in 8 cases there was coexpression between SSTR5 with another SSTR, in 17 cases there were coexpression of more than 2 SSTRs while in one case there were no expression of SSTR. It is worthy to note that between the 8 cases with coexpression between 2 SSTRs, there were only 3 recurrence and there was no a case with muscle invasive disease. In contrast, there were 4 cases with muscle invasive disease in the samples with expression of only SSTR5 (p=0.05). Our results demonstrate for the first time that there is expression of SSTRin bladder cancer and normal bladder urothelium. Further studies are required to evaluate the significance of our findings.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karavitakis, Markos
- Καραβιτάκης, Μάρκος
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40232